data_1ihv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ihv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.409 -0.589 . . . . 4.8099999999999996 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.603 ' N ' ' CD1' ' A' ' 220' ' ' ILE . 0.0 OUTLIER -84.61 119.91 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.105 -1.072 . . . . 2.6400000000000001 108.105 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -79.7 -121.44 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.593 -1.262 . . . . 2.3999999999999999 107.593 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 222' ' ' ASN . 1.4 m-20 -100.62 99.31 9.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.534 -0.914 . . . . 1.9299999999999999 108.534 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.1 146.13 50.49 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.9 . . . . 0.72999999999999998 108.571 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . 0.536 ' NE ' ' OD2' ' A' ' 270' ' ' ASP . 34.2 mtt180 -120.36 160.62 22.68 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.228 -1.027 . . . . 3.75 108.228 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.5 t -142.29 136.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -0.828 . . . . 1.0900000000000001 110.008 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -104.64 156.21 18.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.573 -1.64 . . . . 1.0700000000000001 106.573 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 227' ' ' TYR . 10.4 p90 -156.9 151.57 25.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.494 -1.379 . . . . 0.95999999999999996 110.177 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -93.13 147.04 23.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.74 -0.6 . . . . 2.6200000000000001 109.43 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.94 170.2 10.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 2.25 109.258 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 15.8 t -85.36 -12.99 50.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 2.2200000000000002 109.178 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -90.51 -12.94 35.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 4.0499999999999998 109.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -158.65 129.51 3.69 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.059 -1.025 . . . . 2.3300000000000001 109.524 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.72 4.25 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 120.893 1.062 . . . . 1.1799999999999999 111.189 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.66 154.05 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.484 -1.385 . . . . 2.27 109.75 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -68.67 163.11 24.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 0.57999999999999996 109.598 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 16.2 tttp -119.57 164.58 15.62 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.919 -0.771 . . . . 1.8999999999999999 108.919 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.59 168.76 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.658 -0.977 . . . . 0.56999999999999995 110.658 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.57 161.02 46.89 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.79 1.66 . . . . 0.5 110.485 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.87 177.4 7.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.592 -0.693 . . . . 1.0700000000000001 109.374 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -98.36 139.27 34.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 3.1000000000000001 109.602 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.3 tp -91.05 120.71 32.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.43 -0.794 . . . . 1.1100000000000001 109.15 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.61 -72.91 0.67 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.287 -0.883 . . . . 1.0600000000000001 109.778 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' TRP . . . . . 0.414 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.8 t90 -90.31 142.85 27.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.077 -1.014 . . . . 0.39000000000000001 109.867 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -147.36 121.33 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.365 -0.834 . . . . 2.6699999999999999 109.096 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -103.97 0.22 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.128 -1.189 . . . . 0.44 110.128 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -70.23 -153.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -1.104 . . . . 1.23 109.786 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.02 49.4 2.88 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.328 -1.509 . . . . 0.39000000000000001 109.328 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.43 147.65 29.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.994 . . . . 1.0700000000000001 108.637 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.2 m -141.53 126.24 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 1.0900000000000001 109.648 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.5 135.48 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.698 -1.223 . . . . 1.0900000000000001 107.698 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.1 pt -137.97 178.78 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 110.097 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.427 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.1 tt0 -143.84 113.59 7.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.791 -0.818 . . . . 0.79000000000000004 108.791 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.95 -77.8 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.399 -1.334 . . . . 1.26 107.399 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -81.65 -133.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.531 -1.655 . . . . 2.5699999999999998 106.531 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.0 m -104.03 55.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.793 -1.188 . . . . 1.8899999999999999 107.793 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 255' ' ' SER . 64.6 m-20 -155.56 125.13 6.38 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.796 -0.816 . . . . 1.27 108.796 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.427 ' CG1' HE21 ' A' ' 252' ' ' GLN . 56.6 mt -92.77 137.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -0.887 . . . . 1.05 109.642 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -140.22 169.42 17.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 2.3900000000000001 110.041 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.28 139.63 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.514 -0.741 . . . . 1.1299999999999999 109.026 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 58.2 t -135.36 129.49 18.73 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 1.1100000000000001 108.96 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.72 138.67 86.17 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.633 -0.949 . . . . 0.42999999999999999 109.633 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -58.05 -27.39 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 3.3199999999999998 109.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -68.59 -14.81 63.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.324 -0.86 . . . . 4.1200000000000001 110.316 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -117.88 23.8 11.44 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.303 -0.873 . . . . 2.6200000000000001 108.837 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.16 158.29 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.774 -0.824 . . . . 1.04 108.774 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -137.75 129.41 28.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.488 -0.93 . . . . 2.5899999999999999 108.488 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.11 110.97 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.96 . . . . 1.1599999999999999 109.856 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -108.89 154.29 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.101 -1.074 . . . . 1.1799999999999999 108.101 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -96.1 155.26 16.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.195 -0.941 . . . . 4.6600000000000001 110.653 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.536 ' OD2' ' NE ' ' A' ' 224' ' ' ARG . 1.5 m-20 . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 118.034 -0.984 . . . . 2.23 109.077 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.348 -0.612 . . . . 4.8099999999999996 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -84.98 119.87 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.102 -1.073 . . . . 2.6400000000000001 108.102 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.52 -121.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.603 -1.258 . . . . 2.3999999999999999 107.603 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' B' ' 222' ' ' ASN . 1.4 m-20 -100.59 99.36 9.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.544 -0.91 . . . . 1.95 108.544 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -127.14 146.12 50.5 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.586 -0.894 . . . . 0.72999999999999998 108.586 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . 0.539 ' NE ' ' OD2' ' B' ' 270' ' ' ASP . 34.2 mtt180 -120.37 160.67 22.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.207 -1.034 . . . . 3.7400000000000002 108.207 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.6 t -142.37 136.56 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 1.0900000000000001 109.975 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -104.65 156.2 18.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.511 -1.662 . . . . 1.0700000000000001 106.511 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.449 ' N ' ' CD1' ' B' ' 227' ' ' TYR . 10.2 p90 -156.85 151.63 25.82 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.474 -1.391 . . . . 0.96999999999999997 110.173 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -93.27 147.01 23.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.663 -0.648 . . . . 2.6099999999999999 109.387 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.89 170.06 10.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 2.25 109.232 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.8 t -85.26 -13.02 51.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 2.23 109.275 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -90.41 -13.03 35.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 4.04 109.918 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -158.66 129.46 3.66 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.038 -1.039 . . . . 2.3300000000000001 109.576 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.68 4.25 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 120.923 1.082 . . . . 1.1699999999999999 111.195 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.67 154.07 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.603 -1.31 . . . . 2.2599999999999998 109.721 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -68.68 163.13 24.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.249 -0.907 . . . . 0.58999999999999997 109.552 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' B' ' 237' ' ' GLY . 16.2 tttp -119.56 164.56 15.64 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.867 -0.79 . . . . 1.8999999999999999 108.867 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.63 168.79 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.709 -0.956 . . . . 0.56999999999999995 110.709 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.59 160.95 47.19 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.797 1.665 . . . . 0.51000000000000001 110.474 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.45 7.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.606 -0.684 . . . . 1.0600000000000001 109.412 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -98.45 139.26 34.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.236 -0.915 . . . . 3.1099999999999999 109.643 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 120.74 32.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.444 -0.785 . . . . 1.1000000000000001 109.194 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.55 -72.92 0.67 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.353 -0.842 . . . . 1.0700000000000001 109.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' TRP . . . . . 0.414 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.7 t90 -90.26 142.8 27.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.997 -1.065 . . . . 0.40000000000000002 109.915 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -147.27 121.38 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 2.6699999999999999 109.117 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -103.97 0.22 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.131 -1.188 . . . . 0.44 110.131 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -153.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.24 109.687 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.02 49.33 2.87 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.383 -1.487 . . . . 0.39000000000000001 109.383 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 147.66 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.453 -1.027 . . . . 1.0700000000000001 108.65 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.56 126.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.368 -0.833 . . . . 1.0900000000000001 109.562 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.47 135.35 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.757 -1.201 . . . . 1.0900000000000001 107.757 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.0 pt -137.93 178.8 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 1.0600000000000001 110.125 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.423 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.0 tt0 -143.85 113.54 7.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.825 -0.806 . . . . 0.79000000000000004 108.825 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.92 -77.78 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.401 -1.333 . . . . 1.26 107.401 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -81.63 -133.24 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.493 -1.669 . . . . 2.5699999999999998 106.493 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.0 m -104.08 55.23 0.73 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.779 -1.193 . . . . 1.8799999999999999 107.779 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.5 m-20 -155.52 125.03 6.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.834 -0.802 . . . . 1.27 108.834 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' ILE . . . . . 0.423 ' CG1' HE21 ' B' ' 252' ' ' GLN . 56.6 mt -92.65 137.83 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 1.04 109.632 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -140.15 169.34 17.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.36 -0.838 . . . . 2.3999999999999999 110.112 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.27 139.68 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.022 -0.732 . . . . 1.1299999999999999 109.022 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 58.2 t -135.37 129.54 18.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 1.1100000000000001 108.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.76 138.66 86.27 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 N-CA-C 109.636 -0.948 . . . . 0.41999999999999998 109.636 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -57.96 -27.43 63.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.203 -0.936 . . . . 3.3300000000000001 109.381 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -68.62 -14.73 63.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.428 -0.795 . . . . 4.0999999999999996 110.337 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -117.89 23.78 11.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 2.6200000000000001 108.823 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.11 158.25 44.51 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.704 -0.85 . . . . 1.04 108.704 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -137.73 129.32 28.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.197 -0.939 . . . . 2.5899999999999999 108.558 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.11 110.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 1.1599999999999999 109.91 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.76 154.23 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.167 -1.049 . . . . 1.1899999999999999 108.167 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -96.07 155.27 16.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.242 -0.912 . . . . 4.6600000000000001 110.681 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' ASP . . . . . 0.539 ' OD2' ' NE ' ' B' ' 224' ' ' ARG . 1.5 m-20 . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 117.97 -1.014 . . . . 2.2400000000000002 109.082 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.409 -0.589 . . . . 4.4 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -84.61 119.91 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.105 -1.072 . . . . 2.14 108.105 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -79.7 -121.44 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.593 -1.262 . . . . 2.03 107.593 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 222' ' ' ASN . 1.4 m-20 -100.62 99.31 9.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.534 -0.914 . . . . 1.34 108.534 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.1 146.13 50.49 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.9 . . . . 0.66 108.571 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . 0.536 ' NE ' ' OD2' ' A' ' 270' ' ' ASP . 34.2 mtt180 -120.36 160.62 22.68 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.228 -1.027 . . . . 3.22 108.228 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.5 t -142.29 136.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -0.828 . . . . 0.21 110.008 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -104.64 156.21 18.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.573 -1.64 . . . . 0.55 106.573 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.4 p90 -156.9 151.57 25.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.494 -1.379 . . . . 0.45 110.177 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -93.13 147.04 23.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.74 -0.6 . . . . 2.14 109.43 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.94 170.2 10.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 2.25 109.258 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 15.8 t -85.36 -12.99 50.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 1.78 109.178 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -90.51 -12.94 35.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 3.48 109.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -158.65 129.51 3.69 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.059 -1.025 . . . . 2.33 109.524 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.72 4.25 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 120.893 1.062 . . . . 1.05 111.189 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.66 154.05 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.484 -1.385 . . . . 1.68 109.75 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -68.67 163.11 24.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 0.56 109.598 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 16.2 tttp -119.57 164.58 15.62 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.919 -0.771 . . . . 1.43 108.919 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.59 168.76 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.658 -0.977 . . . . 0.43 110.658 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.57 161.02 46.89 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.79 1.66 . . . . 0.45 110.485 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.87 177.4 7.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.592 -0.693 . . . . 0.24 109.374 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -98.36 139.27 34.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 2.67 109.602 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.3 tp -91.05 120.71 32.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.43 -0.794 . . . . 0.26 109.15 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.61 -72.91 0.67 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.287 -0.883 . . . . 0.27 109.778 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' TRP . . . . . 0.414 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.8 t90 -90.31 142.85 27.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.077 -1.014 . . . . 0.36 109.867 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -147.36 121.33 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.365 -0.834 . . . . 2.08 109.096 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -103.97 0.22 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.128 -1.189 . . . . 0.39 110.128 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -70.23 -153.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -1.104 . . . . 1.23 109.786 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.02 49.4 2.88 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.328 -1.509 . . . . 0.35 109.328 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.43 147.65 29.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.994 . . . . 0.29 108.637 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.2 m -141.53 126.24 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.32 109.648 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.5 135.48 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.698 -1.223 . . . . 0.31 107.698 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.1 pt -137.97 178.78 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.24 110.097 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -143.84 113.59 7.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.791 -0.818 . . . . 0.67 108.791 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.95 -77.8 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.399 -1.334 . . . . 1.26 107.399 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -81.65 -133.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.531 -1.655 . . . . 2.1 106.531 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.0 m -104.03 55.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.793 -1.188 . . . . 1.37 107.793 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 255' ' ' SER . 64.6 m-20 -155.56 125.13 6.38 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.796 -0.816 . . . . 1.27 108.796 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.414 ' CD1' ' CH2' ' B' ' 243' ' ' TRP . 56.6 mt -92.77 137.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -0.887 . . . . 0.36 109.642 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -140.22 169.42 17.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 1.87 110.041 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.28 139.63 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.514 -0.741 . . . . 0.35 109.026 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 58.2 t -135.36 129.49 18.73 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.32 108.96 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.72 138.67 86.17 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.633 -0.949 . . . . 0.37 109.633 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -58.05 -27.39 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 2.87 109.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -68.59 -14.81 63.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.324 -0.86 . . . . 3.65 110.316 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -117.88 23.8 11.44 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.303 -0.873 . . . . 2.06 108.837 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.16 158.29 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.774 -0.824 . . . . 0.27 108.774 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -137.75 129.41 28.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.488 -0.93 . . . . 2.06 108.488 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.11 110.97 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.96 . . . . 0.42 109.856 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -108.89 154.29 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.101 -1.074 . . . . 0.52 108.101 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -96.1 155.26 16.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.195 -0.941 . . . . 4.06 110.653 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.536 ' OD2' ' NE ' ' A' ' 224' ' ' ARG . 1.5 m-20 . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 118.034 -0.984 . . . . 2.23 109.077 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.348 -0.612 . . . . 4.39 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ILE . . . . . 0.821 HD13 ' N ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -84.98 119.87 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.102 -1.073 . . . . 2.15 108.102 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.52 -121.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.603 -1.258 . . . . 2.03 107.603 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' B' ' 222' ' ' ASN . 1.4 m-20 -100.59 99.36 9.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.544 -0.91 . . . . 1.33 108.544 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -127.14 146.12 50.5 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.586 -0.894 . . . . 0.66 108.586 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ARG . . . . . 0.539 ' NE ' ' OD2' ' B' ' 270' ' ' ASP . 34.2 mtt180 -120.37 160.67 22.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.207 -1.034 . . . . 3.22 108.207 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.6 t -142.37 136.56 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.22 109.975 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -104.65 156.2 18.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.511 -1.662 . . . . 0.56 106.511 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.2 p90 -156.85 151.63 25.82 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.474 -1.391 . . . . 0.45 110.173 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -93.27 147.01 23.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.663 -0.648 . . . . 2.13 109.387 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.89 170.06 10.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 2.25 109.232 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.8 t -85.26 -13.02 51.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 1.78 109.275 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -90.41 -13.03 35.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 3.48 109.918 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -158.66 129.46 3.66 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.038 -1.039 . . . . 2.33 109.576 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.68 4.25 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 120.923 1.082 . . . . 1.04 111.195 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.67 154.07 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.603 -1.31 . . . . 1.68 109.721 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -68.68 163.13 24.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.249 -0.907 . . . . 0.57 109.552 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' B' ' 237' ' ' GLY . 16.2 tttp -119.56 164.56 15.64 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.867 -0.79 . . . . 1.43 108.867 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.63 168.79 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.709 -0.956 . . . . 0.43 110.709 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.59 160.95 47.19 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.797 1.665 . . . . 0.45 110.474 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.45 7.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.606 -0.684 . . . . 0.24 109.412 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -98.45 139.26 34.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.236 -0.915 . . . . 2.68 109.643 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 120.74 32.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.444 -0.785 . . . . 0.26 109.194 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.55 -72.92 0.67 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.353 -0.842 . . . . 0.28 109.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' TRP . . . . . 0.414 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.7 t90 -90.26 142.8 27.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.997 -1.065 . . . . 0.36 109.915 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -147.27 121.38 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 2.08 109.117 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -103.97 0.22 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.131 -1.188 . . . . 0.39 110.131 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -153.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.24 109.687 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.02 49.33 2.87 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.383 -1.487 . . . . 0.35 109.383 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 147.66 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.453 -1.027 . . . . 0.29 108.65 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.56 126.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.368 -0.833 . . . . 0.32 109.562 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.47 135.35 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.757 -1.201 . . . . 0.31 107.757 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.0 pt -137.93 178.8 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.24 110.125 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -143.85 113.54 7.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.825 -0.806 . . . . 0.68 108.825 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.92 -77.78 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.401 -1.333 . . . . 1.26 107.401 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -81.63 -133.24 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.493 -1.669 . . . . 2.1 106.493 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.0 m -104.08 55.23 0.73 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.779 -1.193 . . . . 1.36 107.779 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.5 m-20 -155.52 125.03 6.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.834 -0.802 . . . . 1.27 108.834 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' ILE . . . . . 0.414 ' CD1' ' CH2' ' A' ' 243' ' ' TRP . 56.6 mt -92.65 137.83 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.36 109.632 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -140.15 169.34 17.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.36 -0.838 . . . . 1.88 110.112 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.27 139.68 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.022 -0.732 . . . . 0.35 109.022 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 58.2 t -135.37 129.54 18.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.32 108.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.76 138.66 86.27 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 N-CA-C 109.636 -0.948 . . . . 0.37 109.636 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -57.96 -27.43 63.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.203 -0.936 . . . . 2.87 109.381 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -68.62 -14.73 63.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.428 -0.795 . . . . 3.63 110.337 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -117.89 23.78 11.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 2.07 108.823 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.11 158.25 44.51 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.704 -0.85 . . . . 0.28 108.704 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -137.73 129.32 28.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.197 -0.939 . . . . 2.06 108.558 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.11 110.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.42 109.91 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.76 154.23 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.167 -1.049 . . . . 0.53 108.167 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -96.07 155.27 16.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.242 -0.912 . . . . 4.06 110.681 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' ASP . . . . . 0.539 ' OD2' ' NE ' ' B' ' 224' ' ' ARG . 1.5 m-20 . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 117.97 -1.014 . . . . 2.24 109.082 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.409 -0.589 . . . . 4.4 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.828 ' N ' HD13 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -84.61 119.91 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.105 -1.072 . . . . 2.14 108.105 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -79.7 -121.44 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.593 -1.262 . . . . 2.03 107.593 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASN . . . . . 0.485 ' N ' ' OD1' ' A' ' 222' ' ' ASN . 1.4 m-20 -100.62 99.31 9.86 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.534 -0.914 . . . . 1.34 108.534 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -127.1 146.13 50.49 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.571 -0.9 . . . . 0.66 108.571 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . 0.536 ' NE ' ' OD2' ' A' ' 270' ' ' ASP . 34.2 mtt180 -120.36 160.62 22.68 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.228 -1.027 . . . . 3.22 108.228 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 20.5 t -142.29 136.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.375 -0.828 . . . . 0.21 110.008 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -104.64 156.21 18.18 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.573 -1.64 . . . . 0.55 106.573 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 227' ' ' TYR . 10.4 p90 -156.9 151.57 25.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.494 -1.379 . . . . 0.45 110.177 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -93.13 147.04 23.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.74 -0.6 . . . . 2.14 109.43 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.94 170.2 10.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.849 . . . . 2.25 109.258 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 15.8 t -85.36 -12.99 50.88 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 1.78 109.178 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -90.51 -12.94 35.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 3.48 109.87 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -158.65 129.51 3.69 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.059 -1.025 . . . . 2.33 109.524 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.72 4.25 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 120.893 1.062 . . . . 1.05 111.189 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.66 154.05 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.484 -1.385 . . . . 1.68 109.75 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -68.67 163.11 24.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 0.56 109.598 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 237' ' ' GLY . 16.2 tttp -119.57 164.58 15.62 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.919 -0.771 . . . . 1.43 108.919 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 236' ' ' LYS . . . -43.59 168.76 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.658 -0.977 . . . . 0.43 110.658 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.57 161.02 46.89 Favored 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.79 1.66 . . . . 0.45 110.485 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.87 177.4 7.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.592 -0.693 . . . . 0.24 109.374 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -98.36 139.27 34.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 2.67 109.602 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 24.3 tp -91.05 120.71 32.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.43 -0.794 . . . . 0.26 109.15 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.61 -72.91 0.67 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.287 -0.883 . . . . 0.27 109.778 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' TRP . . . . . 0.414 ' CH2' ' CD1' ' B' ' 257' ' ' ILE . 5.8 t90 -90.31 142.85 27.32 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.077 -1.014 . . . . 0.36 109.867 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -147.36 121.33 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.365 -0.834 . . . . 2.08 109.096 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.38 -103.97 0.22 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.128 -1.189 . . . . 0.39 110.128 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -70.23 -153.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -1.104 . . . . 1.23 109.786 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.02 49.4 2.88 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.328 -1.509 . . . . 0.35 109.328 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.43 147.65 29.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.51 -0.994 . . . . 0.29 108.637 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 2.2 m -141.53 126.24 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.32 109.648 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 62.1 t -87.5 135.48 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.698 -1.223 . . . . 0.31 107.698 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ILE . . . . . . . . . . . . . 21.1 pt -137.97 178.78 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.315 -0.866 . . . . 0.24 110.097 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.463 HE21 ' CG1' ' A' ' 257' ' ' ILE . 38.1 tt0 -143.84 113.59 7.14 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.791 -0.818 . . . . 0.67 108.791 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -92.95 -77.8 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.399 -1.334 . . . . 1.26 107.399 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -81.65 -133.29 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.531 -1.655 . . . . 2.1 106.531 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 3.0 m -104.03 55.27 0.73 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.793 -1.188 . . . . 1.37 107.793 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 255' ' ' SER . 64.6 m-20 -155.56 125.13 6.38 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.796 -0.816 . . . . 1.27 108.796 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.463 ' CG1' HE21 ' A' ' 252' ' ' GLN . 56.6 mt -92.77 137.91 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.281 -0.887 . . . . 0.36 109.642 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -140.22 169.42 17.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.387 -0.821 . . . . 1.87 110.041 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.28 139.63 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.514 -0.741 . . . . 0.35 109.026 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 58.2 t -135.36 129.49 18.73 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.318 -0.864 . . . . 0.32 108.96 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.72 138.67 86.17 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.633 -0.949 . . . . 0.37 109.633 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -58.05 -27.39 63.55 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.198 -0.939 . . . . 2.87 109.319 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -68.59 -14.81 63.26 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.324 -0.86 . . . . 3.65 110.316 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -117.88 23.8 11.44 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.303 -0.873 . . . . 2.06 108.837 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.16 158.29 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.774 -0.824 . . . . 0.27 108.774 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -137.75 129.41 28.34 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.488 -0.93 . . . . 2.06 108.488 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.11 110.97 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.96 . . . . 0.42 109.856 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 mm -108.89 154.29 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.101 -1.074 . . . . 0.52 108.101 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -96.1 155.26 16.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.195 -0.941 . . . . 4.06 110.653 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.536 ' OD2' ' NE ' ' A' ' 224' ' ' ARG . 1.5 m-20 . . . . . 0 N--CA 1.501 2.099 0 CA-C-O 118.034 -0.984 . . . . 2.23 109.077 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.348 -0.612 . . . . 4.39 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ILE . . . . . 0.821 HD13 ' N ' ' B' ' 220' ' ' ILE . 0.0 OUTLIER -84.98 119.87 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.102 -1.073 . . . . 2.15 108.102 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -79.52 -121.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.603 -1.258 . . . . 2.03 107.603 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' B' ' 222' ' ' ASN . 1.4 m-20 -100.59 99.36 9.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.544 -0.91 . . . . 1.33 108.544 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -127.14 146.12 50.5 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.586 -0.894 . . . . 0.66 108.586 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . 0.539 ' NE ' ' OD2' ' B' ' 270' ' ' ASP . 34.2 mtt180 -120.37 160.67 22.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.207 -1.034 . . . . 3.22 108.207 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . . 20.6 t -142.37 136.56 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.22 109.975 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -104.65 156.2 18.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.511 -1.662 . . . . 0.56 106.511 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' B' ' 227' ' ' TYR . 10.2 p90 -156.85 151.63 25.82 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.474 -1.391 . . . . 0.45 110.173 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -93.27 147.01 23.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.663 -0.648 . . . . 2.13 109.387 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.89 170.06 10.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.289 -0.882 . . . . 2.25 109.232 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' SER . . . . . . . . . . . . . 15.8 t -85.26 -13.02 51.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 1.78 109.275 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -90.41 -13.03 35.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 3.48 109.918 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -158.66 129.46 3.66 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.038 -1.039 . . . . 2.33 109.576 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -67.68 4.25 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 120.923 1.082 . . . . 1.04 111.195 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' VAL . . . . . . . . . . . . . 2.3 m -81.67 154.07 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.603 -1.31 . . . . 1.68 109.721 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -68.68 163.13 24.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.249 -0.907 . . . . 0.57 109.552 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' B' ' 237' ' ' GLY . 16.2 tttp -119.56 164.56 15.64 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.867 -0.79 . . . . 1.43 108.867 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 236' ' ' LYS . . . -43.63 168.79 0.01 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.709 -0.956 . . . . 0.43 110.709 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.59 160.95 47.19 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.797 1.665 . . . . 0.45 110.474 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -138.77 177.45 7.88 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.606 -0.684 . . . . 0.24 109.412 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -98.45 139.26 34.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.236 -0.915 . . . . 2.68 109.643 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 24.4 tp -91.0 120.74 32.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.444 -0.785 . . . . 0.26 109.194 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.55 -72.92 0.67 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.353 -0.842 . . . . 0.28 109.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' TRP . . . . . 0.414 ' CH2' ' CD1' ' A' ' 257' ' ' ILE . 5.7 t90 -90.26 142.8 27.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.997 -1.065 . . . . 0.36 109.915 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -147.27 121.38 9.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 2.08 109.117 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -155.43 -103.97 0.22 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.131 -1.188 . . . . 0.39 110.131 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -70.25 -153.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.389 -1.065 . . . . 1.24 109.687 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.02 49.33 2.87 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.383 -1.487 . . . . 0.35 109.383 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -148.38 147.66 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.453 -1.027 . . . . 0.29 108.65 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.56 126.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.368 -0.833 . . . . 0.32 109.562 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.47 135.35 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.757 -1.201 . . . . 0.31 107.757 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ILE . . . . . . . . . . . . . 21.0 pt -137.93 178.8 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.24 110.125 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.458 HE21 ' CG1' ' B' ' 257' ' ' ILE . 38.0 tt0 -143.85 113.54 7.1 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.825 -0.806 . . . . 0.68 108.825 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -92.92 -77.78 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.401 -1.333 . . . . 1.26 107.401 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -81.63 -133.24 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.493 -1.669 . . . . 2.1 106.493 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' SER . . . . . 0.415 ' O ' ' OD1' ' B' ' 256' ' ' ASP . 3.0 m -104.08 55.23 0.73 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.779 -1.193 . . . . 1.36 107.779 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 255' ' ' SER . 64.5 m-20 -155.52 125.03 6.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.834 -0.802 . . . . 1.27 108.834 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' ILE . . . . . 0.458 ' CG1' HE21 ' B' ' 252' ' ' GLN . 56.6 mt -92.65 137.83 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.179 -0.951 . . . . 0.36 109.632 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -140.15 169.34 17.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.36 -0.838 . . . . 1.88 110.112 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.27 139.68 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 109.022 -0.732 . . . . 0.35 109.022 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' VAL . . . . . . . . . . . . . 58.2 t -135.37 129.54 18.74 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.32 108.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.76 138.66 86.27 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 N-CA-C 109.636 -0.948 . . . . 0.37 109.636 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -57.96 -27.43 63.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.203 -0.936 . . . . 2.87 109.381 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -68.62 -14.73 63.21 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.428 -0.795 . . . . 3.63 110.337 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -117.89 23.78 11.45 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.238 -0.914 . . . . 2.07 108.823 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' ALA . . . . . . . . . . . . . . . -139.11 158.25 44.51 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.704 -0.85 . . . . 0.28 108.704 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -137.73 129.32 28.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.197 -0.939 . . . . 2.06 108.558 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.11 110.89 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.282 -0.886 . . . . 0.42 109.91 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.2 mm -108.76 154.23 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.167 -1.049 . . . . 0.53 108.167 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -96.07 155.27 16.83 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.242 -0.912 . . . . 4.06 110.681 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' ASP . . . . . 0.539 ' OD2' ' NE ' ' B' ' 224' ' ' ARG . 1.5 m-20 . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 117.97 -1.014 . . . . 2.24 109.082 179.062 . . . . . . . . 1 1 . 1 stop_ save_